Option Fee. For each Isis Reserved Target for which Isis exercises its option granted pursuant to Section 6.2, Isis will pay Alnylam an irrevocable, noncreditable and non-refundable option fee of $[**] due upon the date of exercise. Isis may credit any $[**] payment made under Section 6.4(a) for the Target Slot occupied by such Reserved Target against this option fee. The option fee is only payable once per Gene Target.
Appears in 2 contracts
Sources: Strategic Collaboration and License Agreement (Alnylam Pharmaceuticals Inc), Strategic Collaboration and License Agreement (Alnylam Pharmaceuticals Inc)
Option Fee. For each Isis Reserved DS-Target for which Isis exercises its option granted pursuant to Section 6.2, Isis will pay Alnylam an irrevocable, noncreditable and non-refundable option fee of $[***] due upon the date of exercise. Isis may credit any $[***] payment made under Section 6.4(a) for the DS-Target Slot occupied by such Reserved DS-Target against this option fee. The option fee is only payable once per Gene RNA Target.
Appears in 2 contracts
Sources: Strategic Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.), Strategic Collaboration and License Agreement (Isis Pharmaceuticals Inc)
Option Fee. For each Isis Reserved DS-Target for which Isis exercises its option granted pursuant to Section 6.2, Isis will pay Alnylam an irrevocable, noncreditable and non-refundable option fee of $[**] due upon the date of exercise. Isis may credit any $[**] payment made under Section 6.4(a) for the DS-Target Slot occupied by such Reserved DS-Target against this option fee. The option fee is only payable once per Gene Target.
Appears in 1 contract
Sources: Strategic Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.)
Option Fee. For each Isis Reserved DS-Target for which Isis exercises its option granted pursuant to Section 6.2, Isis will pay Alnylam an irrevocable, noncreditable and non-refundable option fee of $[***] due upon the date of exercise. Isis may credit any $[***] payment made under Section 6.4(a) for the DS-Target Slot occupied by such Reserved DS-Target against this option fee. The option fee is only payable once per Gene Target.
Appears in 1 contract
Sources: Strategic Collaboration and License Agreement (Isis Pharmaceuticals Inc)